Oxidative Stress and Functional Lymphocyte Development
Oxidative Stress and Functional Lymphocyte Development
批准号:
6722919
负责人:
DAVID R KARP
金额:
$27.3万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-01 至 2007-03-31
关键词:
antigen presenting cellantioxidantscell linecytokinedevelopmental immunologyhelper T lymphocytehuman subjectimmunologic memorylipoxygenasemitogen activated protein kinaseoxidative stressperoxidesphlebotomyprotein kinase Crespiratory hypersensitivityshort chain fatty acidsuperoxidestissue /cell culturetocopherols
中文摘要
描述(由申请人提供):儿童哮喘的患病率是
在工业化社会中急剧增加。原因有
尚未完全了解,虽然持续的室内空气过敏原挑战,
暴露于工业污染物和烟草烟雾,以及婴儿细支气管炎
都有牵连从这些研究中,出现了哮喘的概念,
是由于在一个国家中积累的风险因素占优势,
关键序列,在发展的关键时刻。一级预防
哮喘将导致消除或中断任何这些风险。一
这种风险可能是氧化应激和抗氧化剂之间的平衡,
特别是在肺部。最近的证据表明,氧化应激
可能影响小鼠T细胞反应的极化。的影响
氧化应激对人类Th2应答的发展是未知的,
是抗氧化剂的作用。该项目的具体目标是:
1.为了确定暴露于氧化和亚硝化应激如何影响
各种抗原呈递细胞的功能。
2.检测氧化应激是否改变T细胞的Th1/Th2平衡
对抗原的反应
3.为了确定抗氧化剂治疗是否对抗原呈递细胞,
和/或T细胞,将改变T细胞对抗原应答的类型。
不同类型的抗原呈递细胞,包括单核细胞系和
原代细胞(例如,树突状细胞)将受到相关的应激源
并测试它们调节共刺激因子表达的能力。
分子、细胞因子和趋化因子。下生成的APC
然后测试不同的氧化应激条件下
支持或调节T细胞对Th1或Th2应答的极化。
最后,研究了硫醇和非硫醇抗氧化剂调节抗氧化剂的能力。
将确定Th1或Th2应答的诱导。这些实验将
两者都回答了关于免疫反应发展的基本问题,
同时也为合理的临床试验提供了一个框架,
抗氧化剂在关键时刻用于哮喘的初级预防。
英文摘要
DESCRIPTION (provided by applicant): The prevalence of childhood asthma is
increasing dramatically in industrialized societies. The reasons for this are
not completely understood, although persistent indoor aeroallergen challenge,
exposure to industrial pollutants and tobacco smoke, and infant bronchiolitis
have all been implicated. From these studies, the concept emerges that asthma
is the result of a preponderance of accumulated risk factors occurring in a
critical sequence, at a critical time in development. Primary prevention of
asthma will result from elimination or interruption of any of these risks. One
such risk may be the balance between oxidative stress and antioxidants,
particularly in the lung. Recent evidence has suggested that oxidative stress
may influence the polarization of T cell responses in mice. The effects of
oxidative stress on the development of Th2 responses in humans are unknown, as
are the effects of antioxidants. The Specific Aims of this Project are:
1. To determine how exposure to oxidative and nitrosative stress affects the
function of various antigen presenting cells.
2. To test whether oxidative stress alters the Th1/Th2 balance of a T cell
response to antigen.
3. To determine whether antioxidant treatment of antigen presenting cells,
and/or T cells, will alter the type of T cell response to antigen.
Different types of antigen presenting cells, including monocytic cell lines and
primary cells (e.g., dendritic cells) will be subjected to relevant stressors
and tested for their ability to modulate the expression of co-stimulatory
molecules, cytokines, and chemokines. The APC that are generated under
different conditions of oxidative stress will then be tested for the ability to
support or modulate the polarization of T cell responses to Th1 or Th2.
Finally, the ability of thiol and non-thiol antioxidants to modulate the
induction of Th1 or Th2 responses will be determined. These experiments will
both answer fundamental questions about the development of immune responses,
but also provide a framework for rational clinical trials of specific
antioxidants used at critical times for the primary prevention of asthma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
-
批准号:10348096
-
项目类别:
-
资助金额:$93.48万
-
财政年份:2017
-
负责人:DAVID R KARP
-
依托单位:
Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)
-
批准号:9888967
-
项目类别:
-
资助金额:$131.51万
-
财政年份:2017
-
负责人:DAVID R KARP
-
依托单位:
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
-
批准号:8813684
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2015
-
负责人:DAVID R KARP
-
依托单位:
Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus
-
批准号:8996136
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2015
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7941913
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
High Throughput Screening of the Autoimmune Epitome
-
批准号:7937043
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
High Throughput Screening of the Autoimmune Epitome
-
批准号:7842417
-
项目类别:
-
资助金额:$48.88万
-
财政年份:2009
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7673591
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2008
-
负责人:DAVID R KARP
-
依托单位:
Clinical Resource Core
-
批准号:7345037
-
项目类别:
-
资助金额:$12.99万
-
财政年份:2007
-
负责人:DAVID R KARP
-
依托单位:
NIAMS: CORT - Genetic Dissection of SLE--From Mouse to Man
-
批准号:8128710
-
项目类别:
-
资助金额:$147.08万
-
财政年份:2007
-
负责人:DAVID R KARP
-
依托单位:
The Function of Human AIM in Rheumatic Disease
-
批准号:6948562
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2004
-
负责人:DAVID R KARP
-
依托单位:
The Function of Human AIM in Rheumatic Disease
-
批准号:6839655
-
项目类别:
-
资助金额:$15.6万
-
财政年份:2004
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:7034607
-
项目类别:
-
资助金额:$26.66万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6620515
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6418469
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
Oxidative Stress and Functional Lymphocyte Development
-
批准号:6876546
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2002
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6484673
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2001
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6216430
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6344602
-
项目类别:
-
资助金额:$17.9万
-
财政年份:2000
-
负责人:DAVID R KARP
-
依托单位:
CORE--PROTEIN AND MOLECULAR BIOLOGY FACILITY
-
批准号:6201112
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1999
-
负责人:DAVID R KARP
-
依托单位:
海外基金